Literature DB >> 10623726

Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator.

F Kashanchi1, E T Agbottah, C A Pise-Masison, R Mahieux, J Duvall, A Kumar, J N Brady.   

Abstract

Cyclin-dependent kinases are required for the Tat-dependent transition from abortive to productive elongation. Further, the human immunodeficiency virus type 1 (HIV-1) Vpr protein prevents proliferation of infected cells by arresting them in the G(2) phase of the cell cycle. These findings suggest that the life cycle of the virus may be integrally related to the cell cycle. We now demonstrate by in vitro transcription analysis that Tat-dependent transcription takes place in a cell cycle-dependent manner. Remarkably, Tat activates gene expression in two distinct stages of the cell cycle. Tat-dependent long terminal repeat activation is observed in G(1). This activation is TAR dependent and requires a functional Sp1 binding site. A second phase of transactivation by Tat is observed in G(2) and is TAR independent. This later phase of transcription is enhanced by a natural cell cycle blocker of HIV-1, vpr, which arrests infected cells at the G(2)/M boundary. These studies link the HIV-1 Tat protein to cell cycle-specific biological functions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623726      PMCID: PMC111584          DOI: 10.1128/jvi.74.2.652-660.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  92 in total

1.  The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages.

Authors:  N Hattori; F Michaels; K Fargnoli; L Marcon; R C Gallo; G Franchini
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation.

Authors:  M B Feinberg; D Baltimore; A D Frankel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

Review 3.  Regulation of HIV-1 gene expression.

Authors:  B R Cullen
Journal:  FASEB J       Date:  1991-07       Impact factor: 5.191

Review 4.  Temporal events regulating the early phases of the mammalian cell cycle.

Authors:  G S Naeve; A Sharma; A S Lee
Journal:  Curr Opin Cell Biol       Date:  1991-04       Impact factor: 8.382

5.  Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.

Authors:  C Southgate; M L Zapp; M R Green
Journal:  Nature       Date:  1990-06-14       Impact factor: 49.962

6.  HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation.

Authors:  M F Laspia; A P Rice; M B Mathews
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

Review 7.  HIV trans-activation and transcription control mechanisms.

Authors:  K A Jones
Journal:  New Biol       Date:  1989-11

8.  Tat trans-activates the human immunodeficiency virus through a nascent RNA target.

Authors:  B Berkhout; R H Silverman; K T Jeang
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

9.  HIV-1 Tat protein trans-activates transcription in vitro.

Authors:  R A Marciniak; B J Calnan; A D Frankel; P A Sharp
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

10.  Formation of a small ribonucleoprotein particle between Tat protein and trans-acting response element in human immunodeficiency virus-infected cells.

Authors:  K Pfeifer; M Bachmann; H C Schröder; B E Weiler; D Ugarkovic; T Okamoto; W E Müller
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

View more
  25 in total

1.  Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication.

Authors:  M Kameoka; L Rong; M Götte; C Liang; R S Russell; M A Wainberg
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Effect of cell cycle arrest on the activity of nucleoside analogues against human immunodeficiency virus type 1.

Authors:  Sebastien Wurtzer; Séverine Compain; Henri Benech; Allan J Hance; François Clavel
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  The Tat protein of human immunodeficiency virus type 1 (HIV-1) can promote placement of tRNA primer onto viral RNA and suppress later DNA polymerization in HIV-1 reverse transcription.

Authors:  Masanori Kameoka; Max Morgan; Marc Binette; Rodney S Russell; Liwei Rong; Xiaofeng Guo; Andrew Mouland; Lawrence Kleiman; Chen Liang; Mark A Wainberg
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors.

Authors:  D Wang; C de la Fuente; L Deng; L Wang; I Zilberman; C Eadie; M Healey; D Stein; T Denny; L E Harrison; L Meijer; F Kashanchi
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes.

Authors:  Y Zhu; H A Gelbard; M Roshal; S Pursell; B D Jamieson; V Planelles
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1.

Authors:  Karuppiah Muthumani; Andrew Y Choo; Wei-Xing Zong; Muniswamy Madesh; Daniel S Hwang; Arumugam Premkumar; Khanh P Thieu; Joann Emmanuel; Sanjeev Kumar; Craig B Thompson; David B Weiner
Journal:  Nat Cell Biol       Date:  2006-01-22       Impact factor: 28.824

7.  Role of cellular iron and oxygen in the regulation of HIV-1 infection.

Authors:  Sergei Nekhai; Namita Kumari; Subhash Dhawan
Journal:  Future Virol       Date:  2013-03       Impact factor: 1.831

8.  Human GLI-2 is a tat activation response element-independent Tat cofactor.

Authors:  C M Browning; M J Smith; N M Clark; B R Lane; C Parada; M Montano; V N KewalRamani; D R Littman; M Essex; R G Roeder; D M Markovitz
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

9.  Cell cycle regulation of human interleukin-8 gene expression by the human immunodeficiency virus type 1 Tat protein.

Authors:  R Mahieux; P F Lambert; E Agbottah; M A Halanski; L Deng; F Kashanchi; J N Brady
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

10.  Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA.

Authors:  Betty Poon; Michael A Chang; Irvin S Y Chen
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.